Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 November 2014 11:55
Experts have found that eribulin can extend the lives of women with aggressive forms of breast cancer by several months
Giving breast cancer patients a drug made from sea sponges can extend their lives by several months, according to a new study.
Researchers at the University of Leeds carried out two large-scale trials with more than 1,800 participants who had been diagnosed with metastatic breast cancer.
They found that the drug eribulin extended the women's survival by an average of more than two months.
Women who had advanced triple negative breast cancer - an aggressive form of the disease for which there are few treatment options - benefited the most from the drug, with their lifespans increasing by almost five months.
Those with HER2 negative breast cancer lived more than two months longer when given eribulin, it was found.
Martin Ledwick, head information nurse at Cancer Research UK, described the results as "encouraging" for those women whose cancers no longer respond to conventional treatments.
He said that eribulin is not a cure but an additional option to extend patients' lives - which could be "priceless" for the women and their families. It may give them the option to spend valuable time with their family and friends, or to embark on a holiday with the security provided by specialist travel insurance for cancer patients.
The drug was originally derived from Halichondria okadai, a sea sponge, although it is now produced in laboratories.
Chris Twelves, professor of clinical cancer pharmacology and oncology at the University of Leeds, said the findings show that eribulin can lead to a "substantial improvement" in women's survival rates.
He pointed out that, while the drug was previously only available for women who had undergone several rounds of chemotherapy, the EU has now also approved it for those who have not received as much treatment.
The findings of the study were presented at the National Cancer Research Institute's cancer conference in Liverpool.
03 December 2016
Thousands of Britons could be heading off on snow-sports holidays without appropriate travel insurance cover, it has been warned.
01 December 2016
Pilots at German airline Lufthansa are on strike again after a two-day break in their campaign of walkouts.
02 December 2016
Britons are among the top spenders in Europe when it comes to holidays, new research has found.
30 November 2016
The UK should think about resuming flights to the popular tourism resort of Sharm el-Sheikh, according to a major United Nations agency.
29 November 2016
Plans are in place to develop a new aviation arrangement between the UK and US, to ensure holidaymakers can still fly between the two countries once Britain departs the EU.
26 November 2016
Hundreds of Lufthansa flights have been grounded after pilots working for the airline took part in a strike.
25 November 2016
The US is warning its citizens that Europe is facing a "heightened risk of terror attacks" at Christmas markets and other seasonal holiday events.
24 November 2016
A groundbreaking radiotherapy machine that can track the changing position of tumours in real time will soon be used to treat cancer patients in the UK.
23 November 2016
Top airline bosses are urging the government to scrap air passenger duty ahead of Wednesday's Autumn Statement.
22 November 2016
Winter sun is now the most popular holiday type, according to new research conducted by travel experts.
19 November 2016
A holiday price increase of 10% on trips to Europe could cause tourists to postpone their getaways next year, experts are warning.
18 November 2016
British citizens will no longer be able to travel freely to Europe without paying a "travel tax" or filling in visa forms under plans unveiled by Brussels.